Research and Markets: Global Depression Therapy & Treatment Market Trends and Forecasts 2014-2020

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/pfqhdl/global_depression) has announced the addition of the "Global Depression Therapy & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering.

This report studies a number of facts based on the data collected over the years. Studies over the years suggest that females all over the world, are more susceptible to being diagnosed as clinically depressed. This report includes studies based on a wide geographical range observing the percentage of diagnosis recorded in various regions of the world in order to get a better understanding of this disease. Geographically, North Africa and Middle Eastern countries have seen the highest prevalence rate of depression whereas North American countries have a moderate prevalence rate, while Japan has the lowest prevalence rate of depression. The report analyses the different market segments that exist here in the form of all possible treatments.

There are various methods to treat depression which include antidepressants drug therapies, various interpersonal therapies like Cognitive Behavior Therapy (CBT) and rational emotive behavior therapy (REBT), electroconvulsive therapy, psychodynamic therapy and therapies which involve use of neuro-technology and virtual reality. In the case of a situation where the patients do not respond to the existing treatments, 21st century and technological advancements have offered the possibility of specific devices that aid overcoming depression.

This report, in addition to addressing the existing therapies, also focuses on these devices- Fischer Wallace Stimulator, Transcranial Magnetic Stimulator, Deep Brain Stimulator, Virtual reality, Light Therapy, Vagus Nerve Simulator, Smart phone applications, Assistive technology.

Key Topics Covered:

1. Depression Therapy

2. Executive Summary

3. Market Overview

4. Market Determinants

5. Market Segmentation

6. Special Conditions

7. Depression treatment centers and rehabilitation centers

8. Generic medicines vs. Branded medicines

9. Competitive Intelligence

10. Market Share Analysis

11. Geography Analysis

12. Corporate Profiling

  • Pfizer
  • GlaxoSmithKline
  • Forest Labs
  • SunPharma
  • Eli lily and company
  • Mayo Clinic
  • Neurostar
  • Brainsway
  • Fisher Wallace
  • MagVanture

For more information visit http://www.researchandmarkets.com/research/pfqhdl/global_depression

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices